September 12, 2012
Held approximately 100 days after the 2 July effective date, Impact of the New European Pharmacovigilance Legislation is designed to promote discussion regarding current and ongoing implementation efforts. An array of industry and regulatory experts will be on hand 15 October at the BMA House in London to discuss ongoing efforts, successes and challenges. Claire Tilstone, Editor, The Medicines and Health Products Regulatory Agency Paul Dolin, Director, Takeda Pharmaceuticals Sinem Ezgi Gulmez, Associate Professor of Pharmacology, Pharmacoepidemiology and Drug Safety, University Bordeaux Segalen Francois Simondon, Epidemiology Executive Director, Sanofi Pasteur MSD Macey Murray, Teaching and Research Fellow, University College London, Centre for Paediatric Pharmacy Research Saad A.W...Research Trust is a non-profit organization facilitating access to information in the fields of Patient-Reported Outcomes (PRO) and Epidemiology, promoting the use of scientific approaches in these fields and encouraging exchanges between academics, companies, and international organizations around the world. Founded in 1995, headquarters are located in Lyon, France.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/9/prweb9894660.htm